{"entity":{"id":"nct01276054","kind":"trial","name":"Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients","aka":[],"tldr":"A phase 2 trial of Technetium Tc-99m sulfur colloid in Breast cancer, run by University of Southern California, recorded as terminated on the registry.","summary":"Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients is a phase 2 interventional study registered as NCT01276054 by University of Southern California, with 4 participants recorded, started 2010-12 and due to reach its primary completion in 2011-10. Interventions recorded: technetium Tc 99m sulfur colloid, methylene blue, indocyanine green solution, sentinel lymph node biopsy, axillary lymph node biopsy, bioimpedance spectroscopy, quality-of-life assessment, lymphedema management. Conditions recorded: Lymphedema, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer.\n\nLinked to the drug Technetium Tc-99m sulfur colloid because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT01276054","url":"https://clinicaltrials.gov/study/NCT01276054"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["technetium-sulfur-colloid"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01276054","phase":"2","setting":"Reducing the Incidence and Severity of Arm Lymphedema With Axillary Reverse Mapping and Implementation of a Lymphedema Screening and Intervention Program","sponsor":"University of Southern California","participation":[{"nct":"NCT01276054","source":"https://clinicaltrials.gov/study/NCT01276054","fetchedAt":"2026-10-07T16:52:24.100Z","studySha256":"100fe052f7c839f881dca90f62d563511c3dacd95c6d7b73be0cf83cd7f3a323","overallStatus":"TERMINATED","lastUpdatePosted":"2014-08-01","whyStopped":"P.I. left","leadSponsor":"University of Southern California","collaboratorCount":1,"minimumAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":4,"enrolmentType":"ACTUAL","siteCount":1,"recruitingSiteCount":0,"countries":["United States"]}],"started":"2010-12","enrolled":4,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01276054/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"drug":[{"id":"technetium-sulfur-colloid","kind":"drug","name":"Technetium Tc-99m sulfur colloid","route":"/drugs/technetium-sulfur-colloid/"}]}}